1. Home
  2. SIF vs HURA Comparison

SIF vs HURA Comparison

Compare SIF & HURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SIFCO Industries Inc.

SIF

SIFCO Industries Inc.

N/A

Current Price

$13.27

Market Cap

80.2M

Sector

Industrials

ML Signal

N/A

Logo TuHURA Biosciences Inc.

HURA

TuHURA Biosciences Inc.

N/A

Current Price

$1.67

Market Cap

87.5M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
SIF
HURA
Founded
1913
2009
Country
United States
United States
Employees
N/A
19
Industry
Office Equipment/Supplies/Services
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
80.2M
87.5M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
SIF
HURA
Price
$13.27
$1.67
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
156.2K
2.5M
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
86.67
N/A
EPS
0.29
N/A
Revenue
$111,212,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$44.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.33
$0.41
52 Week High
$15.00
$4.41

Technical Indicators

Market Signals
Indicator
SIF
HURA
Relative Strength Index (RSI) 62.37 66.78
Support Level $5.92 $1.56
Resistance Level N/A $1.83
Average True Range (ATR) 1.38 0.19
MACD -0.13 0.01
Stochastic Oscillator 65.25 80.46

Price Performance

Historical Comparison
SIF
HURA

About SIF SIFCO Industries Inc.

SIFCO Industries Inc produces forgings, sub-assemblies, and machined components for the Aerospace and Energy markets. Its services include forging, heat treating, machining, surface treatment, non-destructive testing, and sub-assembly of forged components. The company manufactures envelopes and precision forgings, as well as rough and finished machined parts, serving OEMs, Tier 1 and Tier 2 suppliers, and aftermarket providers across Aerospace, Defense, Energy, and Commercial Space. Its Products are made from steel, high-temperature alloys, nickel alloys, titanium, and aluminum, and include components for aircraft and industrial gas turbine engines, airframe structures, landing gear, wheels and brakes, helicopter rotating parts, and other commercial and industrial applications.

About HURA TuHURA Biosciences Inc.

TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.

Share on Social Networks: